Pridham Report: Fidelity sees sharp growth in Q1 2022

Fidelity gross sales up 60%

Elliot Gulliver-Needham
clock • 1 min read

Despite a downturn in markets and the first quarter of net negative retail flows since the pandemic began, top UK fund managers have maintained strong sales so far in 2022, according to the Pridham Report.

Fidelity had an especially solid first quarter, taking second place in gross sales and first place in net flows. Gross sales of Fidelity's equity funds have increased by 60% compared to last quarter, with its Global Dividend fund being the fourth best-selling retail product in the UK fund market. JP Morgan also did well, returning to the top ten for both gross and net sales in Q1, partially due to demand for North American equities in both its offshore JPM America Equity fund and onshore US Equity Income fund. Other beneficiaries of the swell in North American popularity includes HSBC...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Advisers zoomed in on capital accumulation in Q4 2025

Advisers zoomed in on capital accumulation in Q4 2025

Titan Square Mile research finds

Jen Frost
clock 30 January 2026 • 3 min read
Measure for measure: How to track your tracker fund

Measure for measure: How to track your tracker fund

Tracking difference and tracking error

Terry McGivern
clock 28 January 2026 • 3 min read
SJP and AJ Bell pivot from US mega-caps in MPS as concentration woes continue

SJP and AJ Bell pivot from US mega-caps in MPS as concentration woes continue

Healthcare, energy and EM preferred

Linus Uhlig
clock 28 January 2026 • 2 min read